Peptidomics Firm PXBioVision Hopes to Succeed Where it Failed in a Former Life as Digilab BioVision
October 01, 2009
Peptidomics Firm PXBioVision Hopes to Succeed Where it Failed in a Former Life as Digilab BioVision
The German company Digilab BioVision was declared insolvent in late 2008, but seven former employees have resurrected the company as PXBioVision, hoping to take it and peptidomics to new levels.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Samples Available for PRG 2012 Intra-Lab QC and Reproducibility Study
January 13, 2012 / ProteoMonitor - People in the News: Eric Bouvier; Alan Marshall; and More
January 13, 2012 / ProteoMonitor - NCI Kicks Off Second Stage of Clinical Proteomic Technologies for Cancer Initiative
August 26, 2011 / ProteoMonitor - Yale-Led Group Links Protein Markers to Kidney Injury in Cardiac Surgery Patients
August 26, 2011 / ProteoMonitor - Bio-Rad Develops More Sensitive, Streamlined Workflow for SPR-Mass Spec
August 26, 2011 / ProteoMonitor